Magstim Logo

TMS Provider Spotlight – a Q&A with Khaled Bowarshi MD

We spoke with Dr Bowarshi from his Florida TMS Clinic. Dr Bowarshi is board-certified in both Internal Medicine and Psychiatry.

Magstim Group Appoints Luciën van Os as Chief Technology Officer for Global Minimally-Invasive Neurotechnology Portfolio

Van Os To Oversee Product & Technology Development For Magstim TMS, Electrical Geodesics (EGI) EEG, Technomed Neurophysiology and Neurosign Intraoperative Nerve Monitoring Brands

By |2020-11-10T11:34:33+00:00August 21st, 2020|Company News|0 Comments

Rhythm and Acceleration in TMS – Magstim Academy June 11th

Magstim Academy Lecture Series – Rhythm and Acceleration - recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.

By |2020-11-05T16:09:34+00:00May 29th, 2020|Company News|0 Comments

Magstim TMS receives FDA clearance for 3- minute theta burst treatment

Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.

By |2020-11-05T17:53:09+00:00March 29th, 2019|Company News, Mental Health, TMS Therapy|0 Comments

NHS clinical trial could pave the way for new depression treatment

How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).

By |2020-11-05T19:22:47+00:00November 19th, 2018|Company News, TMS Therapy|0 Comments